Charles Russell Speechlys advises Kreos Capital V (UK) Limited on senior secured loan to Pharming Group NV
Charles Russell Speechlys LLP advised Kreos Capital V (UK) Limited (“Kreos”) on its €21 million senior secured loan to Pharming Group NV (“Pharming”) and its subscription for €6 million subordinated redeemable convertible bond issued by Pharming.
The transaction is part of a larger fundraising exercise carried out by Pharming to raise €104 million before costs (comprising of straight debt, convertible bonds and proceeds of rights issue) to, amongst others, acquire all commercialisation rights to its own product RUCONEST® in North America and to repay its existing debt facility.
The Charles Russell Speechlys core team comprised Corporate Partner Chris Putt, Corporate Associates Rossana Conti and Amelly Kok and Banking Partner Daniel Sullivan.
News & Insights
Real Estate and Construction Newsletter – December 2017
Welcome to our December newsletter, bringing you legal insight into issues facing the property industry.
The Department of Health wants to axe health regulators, but should the GPhC stay?
David Reissner explains why there may be a case for the GPhC to be retained if other healthcare regulators are scrapped.